Tiziana Life Sciences plc, of London, sold 442,910 shares of stock at $9.90 each to raise $4.4 million. The offer price is about the same as the as-converted price of Tiziana's common shares listed on London's stock exchange. The company is focused on cancer and autoimmune diseases.